Evercare Hospital avails its success in Patent Foramen Ovale device closure 

Corporates

TBS Report
02 November, 2020, 05:25 pm
Last modified: 02 November, 2020, 05:30 pm
A Bangladeshi consultant with his team has completed the entire process on October 18

Evercare Hospital Dhaka has become the nation's first ever successful PFO (Patent Foramen Ovale) Device Closure on a young lady (age 27) with Cryptogenic Stroke (ischemic CVD).

A Bangladeshi consultant with his team has completed the entire process on October 18, says a press release.

The highly skilled procedure has become possible as it got the logistical support of the hospital. They also got success in another procedure on a 37-year old woman on October 28. 

These specialists are at the front lines for patients who suffer from this kind of stroke or disease. Their expertise have laid the foundation for further successes with confidence. The hospital believes that together, they can help even more distressed patients who need this kind of complex surgical procedures in future.

Brain strokes develop when brain tissue is deprived of blood supply. This stroke is said to be cryptogenic when the cause is unknown. The most common cause for such cryptogenic stroke is caused by paradoxical embolism through a PFO, as per the scientific data.

Evercare Hospital is the only JCI accredited Hospital in Bangladesh with international-standard healthcare. It is a part of Evercare Group, serving in six countries with 29 hospitals, 16 clinics and 57 diagnostic centers across two continents. The mission of the hospital is to provide quality healthcare in emerging markets.

The team members include Clinical & Interventional Cardiology Department' Senior Consultant & Coordinator Prof Dr AQM Reza, Senior Registrar Dr Aparajita Karim and Register Dr Mahmood Hasan Khan, and Cath-lab Team. They want to inform Neurologist & Neurosurgeon colleagues all over the country about their historic achievement.

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.